The global biomaterials market was valued at USD 215.92 Billion in 2025. It is expected to grow at a CAGR of 12.40% during the forecast period of 2026-2035 and attain a market value of USD 694.95 Billion by 2035. The market growth is driven by the rising prevalence of chronic diseases and aging population across the globe. Patent applications are focused on advanced technologies such as natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial among others.
The need for prosthetics, medical implants, and other biomaterials is rising with the growing geriatric population on a global level. Elder people may require dental implants, joint replacements, and other medical devices more frequently.
With the creation of novel biomaterials, patent applications are expected to witness growth in the coming years.
Advancements in biotechnology, including tissue engineering and regenerative medicine are some of the major factors.
The increasing prevalence of chronic illnesses such as diabetes, heart disease, and cancer increases the demand for biomaterials in medical devices and treatments.
The Global Biomaterials Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for biomaterials include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with biomaterials. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within biomaterial technologies.
Patent Valuation Analysis
An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for biomaterial technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Biomaterials.
Analysis of Patent Applications
A comprehensive summary of several patent applications which were filed across different jurisdictions for biomaterials and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Analysis of Granted Patents
Detailed analysis of the granted patents across different jurisdictions for biomaterials and their relative value in the IP are covered in the final report.
Materials designed to interact with biological systems in a medical context are called biomaterials. They are utilized in drug delivery systems, prosthetics, and implants to improve or restore biological functions. These materials are intended to be biocompatible and useful within the body and can be synthetic, natural, or a combination of both.
The components of biomaterials include natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Natural biomaterials are biocompatible and can integrate with living tissues such as collagen, chitosan, and hyaluronic acid. They are utilized in medical applications and reduce the possibility of rejection and promote healing by closely resembling the structure and functionality of natural tissues. Their applications range from tissue engineering to wound dressings.
Advancements in Biotechnology are Expected to Boost the Patent Industry Growth
Innovative biomaterials, like those used in tissue engineering and regenerative medicine, are being developed because of technological breakthroughs in biotechnology. These materials provide new avenues for treatment and better patient outcomes. For instance, Axiom Biologic Scaffold from Medtronic is a cutting-edge tissue engineering product designed to be used in the restoration of damaged cardiac tissue. Advanced biomaterials included in this scaffold support tissue regeneration and blend in perfectly with the body's native tissues.
The discovery marks a substantial advancement in biotechnology and demonstrates how developments are producing novel and improved biomaterials for regenerative medicine. Patents covering these technologies are crucial for companies and thus impact the biomaterials patent landscape. As a result, there is an increase in patent activity which focuses on enhancing the performance of biomaterials. There were 3,633 patents granted in 2022 and this number increased to 3,817 patent grants by 2023.
Rising Aging Population is Expected to Propel the Biomaterials Patent Industry
The need for biomaterials is fueled by the aging of the world's population, as older people frequently need prosthetic limbs, medical implants, and other supportive devices to maintain their quality of life.
The report will cover the following sections in detail:
Analysis by Type of Biomaterial
The breakup based on the type of biomaterial includes natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Metallic biomaterials, like titanium and stainless steel, are metals that are used in medical implants and devices because of their strength, toughness, and biocompatibility. They engage in interactions with biological systems that facilitate tissue integration and healing.
Detailed technological data will be provided for all specified segments classified in this report.
The United States is one of the leading jurisdictions for biomaterial patents, having around 100,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.
Among the players with biomaterial patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the biomaterials field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
It was established in 1861 with its headquarters located in Cambridge, Massachusetts. The goal of MIT's biomaterials research is to create cutting-edge materials for use in tissue engineering and regenerative medicine, among other medical fields. To turn its discoveries into workable solutions for health and medicine, the Institute partners with a range of businesses and start-ups.
It is a division of Boston Scientific Corporation with its headquarters located in Maple Grove, Minnesota founded in 1979 with a focus on biomaterials and medical devices. The company's primary focus is on creating novel approaches to endoscopic and cardiovascular procedures, leveraging cutting-edge biomaterials to improve device functionality and patient outcomes. Stents, drug-eluting technologies, and other state-of-the-art medical devices are some of its contributions to the field of biomaterials.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Apatech Ltd, Coloplast AS, Fujifilm Corp, Ethicon LLC, Centre Nat Rech Scient, Novartis AG, Vysera Biomedical Limited, Dexcom Inc., Cilag Gmbh Int, Warsaw Orthopedic Inc., Allergan Inc., Abbott, Medtronic Inc., Cook Medical Technologies LLC, Zimmer INC., among others.
The biomaterials patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -
Global Orthopaedic Biomaterials Market
Upto 35% Off
USD
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| Scope of the Report | Details |
| Analysis by Type of Biomaterial |
|
| Key Players Mentioned |
|
| Geographies Covered |
|
Mini Report
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share